Video Experimental Relacionado
Updated: Feb 28, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Complicaciones y oportunidades pasadas por alto en el desarrollo de fármacos basados en péptidos macrobicíclicos: el
Isabelle J Smith1, Simon M Popovic1, John A Gladysz1
1Department of Chemistry, Texas A&M University, PO Box 30012, College Station, Texas 77842-3012, United States.
Abstract:
Many macrobicyclic compounds can undergo a widely overlooked conformational process, homeomorphic isomerization, that effectively turns molecules inside-out and leads to species with in,in, out,out, in,out, and out,in bridgeheads. Different chemical and biological properties would be expected. Some foundational aspects of this phenomenon are briefly reviewed, with both model compounds of the formula E((CH2)n)3E (n ≥ 10, E = P, As, etc.) and macrobicyclic peptides. Attempts are made to bridge the differing cultural perspectives of the physical organic and chemical biology communities regarding bicyclic molecules. Opportunities are presented for (1) improving the stereochemical definition of macrobicyclic peptides and their adducts with proteins, (2) new drug design and efficacy protocols, and (3) refining or circumventing existing patented IP.
Videos de Conceptos Relacionados
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Drug Discovery: Overview
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Prodrugs
Prodrugs help overcome...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

